Michael Scolaro

Michael Scolaro

Oct 07, 2017

Group 6 Copy 215
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can cockroaches help us cure tularemia?

Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

Can people be screened for acute mountain sickness susceptibility?

This project aims to investigate cerebral deoxygenation during exercise in hypoxia in order to highlight a potential...

Why is breast cancer detection important?

Breast cancer is the most common cancer among Latino women. We're creating a fotonovela to reach these women...

Backer Badge Funded